Skip to content

EFFFECTIVENESS OF EPIDURAL MORPHINE IN POST CESAREAN ANALGESIA

EFFECTIVENESS OF EPIDURAL MORPHINE FOR POST- CESAREAN ANALGESIA

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20231008003
Enrollment
100
Registered
2023-10-08
Start date
2022-11-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

past cesarean analgesia past-cesarean analgesia, morphine, epidural

Interventions

Epidural morphine given ,This group did not recieved morphine
Active Comparator Drug,No Intervention No treatment
group M(Morphine),Group B

Sponsors

CMH
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA II full-term (37-40 weeks) multiparous parturient, age between 18-40 years, scheduled for elective Lower Segment Cesarean Section (LSCS)

Exclusion criteria

Exclusion criteria: patient's refusal for spinal or epidural anaesthesia, known or suspected dural puncture, body mass index > 30 kg/m2, twin pregnancy, patients with a medical history of hypertension, diabetes, PIH/ eclampsia, suffering from major pulmonary or cardiovascular disease, thrombocytopenia, allergic to local anaesthetic/ morphine, patients with a history of Obstructive Sleep Apnea.

Design outcomes

Primary

MeasureTime frame
Analgesia Duration 2,4,8,12,16,,20 24 hrs Time

Secondary

MeasureTime frame
Respiratory Depression 2,4,8,12,16,,20 24 hrs No of breaths,PONV 2,4,8,12,16,,20 24 hrs no of times,Pruitus 2,4,8,12,16,,20 24 hrs mild , severe

Countries

Pakistan

Contacts

Public ContactIHTISHAM UL HAQ

AFHJ

drihtisham@outlook.com00923219603695

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026